Skip to content
10-K

Annual Report

Apollo Endosurgery, Inc.

0001251769-22-000006

← back to feed
Filed
Feb 22, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Jan 31, 2022 39.62M sh
Short Term Debt FY 2021 · Dec 31, 2021 $0
Short Term Debt FY 2021 · Dec 31, 2020 $636K
Cost Of Revenue FY 2021 · Dec 31, 2021 $28.03M
Cost Of Revenue FY 2021 · Dec 31, 2020 $19.81M
Shares Diluted FY 2021 · Dec 31, 2020 22.76M sh
Capex FY 2021 · Dec 31, 2020 $486K
Operating Cash Flow FY 2021 · Dec 31, 2020 −$20.81M
Long Term Debt FY 2021 · Dec 31, 2020 $37.19M
Cash And Equivalents FY 2021 · Dec 31, 2020 $36.24M
Current Liabilities FY 2021 · Dec 31, 2020 $11.67M
Total Liabilities FY 2021 · Dec 31, 2020 $70.69M
Current Assets FY 2021 · Dec 31, 2020 $58.53M
Total Assets FY 2021 · Dec 31, 2020 $77.44M
Eps Diluted FY 2021 · Dec 31, 2020 −$0.99
Eps Basic FY 2021 · Dec 31, 2020 −$0.99
Sga Expense FY 2021 · Dec 31, 2020 $11.06M
Rd Expense FY 2021 · Dec 31, 2020 $7.67M
Net Income FY 2021 · Dec 31, 2020 −$22.61M
Operating Income FY 2021 · Dec 31, 2020 −$15.79M
Gross Profit FY 2021 · Dec 31, 2020 $22.24M
Revenue FY 2021 · Dec 31, 2020 $42.05M
Stockholders Equity FY 2021 · Dec 31, 2019 $2.12M